---
title: "Concord Biotech shares locked in 20% lower circuit after weak Q3 earnings"
date: "2025-02-14 17:10:51"
summary: "Concord Biotech shares locked in 20% lower circuit after weak Q3 earnings Trade Watchlist Portfolio Message Set Alert livebselivenselive Volume Todays L/H More × Concord Biotech shares were locked in 20 percent lower circuit in February 14 trade after the weak third quarter results for the current fiscal.The shares of..."
categories:
  - "moneycontrol"
lang:
  - "en"
translations:
  - "en"
tags:
  - "moneycontrol"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

![Concord Biotech shares locked in 20% lower circuit after weak Q3 earnings](//stat1.moneycontrol.com/mcnews//images/grey_bg.gif "Concord Biotech shares locked in 20% lower circuit after weak Q3 earnings")

Concord Biotech shares locked in 20% lower circuit after weak Q3 earnings
-------------------------------------------------------------------------

  


  Trade

* [Watchlist](javascript:void(0);)
* [Portfolio](javascript:void(0);)
* [Message](javascript:void(0);)
* [Set Alert](javascript:void(0);)

      live

* bselive
* nselive

    Volume  Todays L/H    ![]()   [More](javascript:void(0))   × 

Concord Biotech shares were locked in 20 percent lower circuit in February 14 trade after the weak third quarter results for the current fiscal.

The shares of [Concord Biotech Ltd.](https://www.moneycontrol.com/india/stockpricequote/biotechnologymedical-research/concordbiotech/CB08) dropped 20 percent to an intraday low of Rs 1,689.4 per share on the NSE. The stock opened with a loss of 5.29 percent. The scrip has been falling for the last five trading sessions, with its market cap dropping to Rs 17,673.86 crore on the NSE.

***Disclaimer:** The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.*

[moneycontrol](https://www.moneycontrol.com/news/business/markets/concord-biotech-shares-locked-in-20-lower-circuit-after-weak-q3-earnings-12941180.html)
